| Экспресс-диагностика в детском саду. Комплект материалов для педагогов-психологов детских дошкольных образовательных учреждений НН Павлова, ЛГ Руденко М.: Генезис, 56-73, 2008 | 185 | 2008 |
| Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses X Lu, LE Edwards, JA Desheva, DC Nguyen, A Rekstin, I Stephenson, ... Vaccine 24 (44-46), 6588-6593, 2006 | 147 | 2006 |
| Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents LG Rudenko, NH Arden, E Grigorieva, A Naychin, A Rekstin, AI Klimov, ... Vaccine 19 (2-3), 308-318, 2000 | 108 | 2000 |
| Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2) I Isakova-Sivak, LM Chen, Y Matsuoka, JTM Voeten, I Kiseleva, ... Virology 412 (2), 297-305, 2011 | 95 | 2011 |
| Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium NA Ilyushina, MR Ikizler, Y Kawaoka, LG Rudenko, JJ Treanor, ... Journal of virology 86 (21), 11725-11734, 2012 | 79 | 2012 |
| Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza … L Rudenko, H van den Bosch, I Kiseleva, A Mironov, A Naikhin, ... Vaccine 29, A40-A44, 2011 | 70 | 2011 |
| Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials) L Rudenko, J Desheva, S Korovkin, A Mironov, A Rekstin, E Grigorieva, ... Influenza and other respiratory viruses 2 (6), 203-209, 2008 | 66 | 2008 |
| PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus IV Kiseleva, JTM Voeten, LCP Teley, NV Larionova, ... Journal of general virology 91 (4), 931-937, 2010 | 65 | 2010 |
| Assessment of human immune responses to H7 avian influenza virus of pandemic potential: Results from a placebo–controlled, randomized double–blind phase I study of live … L Rudenko, I Kiseleva, AN Naykhin, M Erofeeva, M Stukova, S Donina, ... PloS one 9 (2), e87962, 2014 | 64 | 2014 |
| Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine D Korenkov, I Isakova-Sivak, L Rudenko Expert review of vaccines 17 (11), 977-987, 2018 | 59 | 2018 |
| Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories L Rudenko, L Yeolekar, I Kiseleva, I Isakova-Sivak Vaccine 34 (45), 5436-5441, 2016 | 58 | 2016 |
| Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets KM Gustin, TR Maines, JA Belser, N van Hoeven, X Lu, L Dong, ... Journal of Infectious Diseases 204 (10), 1491-1499, 2011 | 55 | 2011 |
| H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial L Rudenko, I Isakova-Sivak, A Naykhin, I Kiseleva, M Stukova, M Erofeeva, ... The Lancet Infectious Diseases 16 (3), 303-310, 2016 | 49 | 2016 |
| Safety, immunogenicity and infectivity of new live attenuated influenza vaccines I Isakova-Sivak, L Rudenko Expert Review of Vaccines 14 (10), 1313-1329, 2015 | 45 | 2015 |
| Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin I Isakova-Sivak, D Korenkov, T Smolonogina, T Kotomina, S Donina, ... Virology 518, 313-323, 2018 | 40 | 2018 |
| H7N9 live attenuated influenza vaccine is highly immunogenic, prevents virus replication, and protects against severe bronchopneumonia in ferrets J De Jonge, I Isakova-Sivak, H Van Dijken, S Spijkers, J Mouthaan, ... Molecular Therapy 24 (5), 991-1002, 2016 | 38 | 2016 |
| H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus L Rudenko, I Isakova-Sivak, S Donina Vaccine 31 (42), 4702-4705, 2013 | 38 | 2013 |
| Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a … G Petukhova, A Naikhin, T Chirkova, S Donina, D Korenkov, L Rudenko Vaccine 27 (19), 2580-2587, 2009 | 37 | 2009 |
| Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg-or cell culture-derived reassortants T Palker, I Kiseleva, K Johnston, Q Su, T Toner, C Szymkowiak, WS Kwan, ... Virus research 105 (2), 183-194, 2004 | 36 | 2004 |
| Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a … P Pitisuttithum, K Boonnak, S Chamnanchanunt, P Puthavathana, ... The Lancet Infectious Diseases 17 (8), 833-842, 2017 | 35 | 2017 |
